Jump to content
Company database

Synovo GmbH

Synovo GmbH is a German-based pharmaceutical discovery company. Synovo has a dual model of services to the Pharmaceutical industry and internal discovery. Synovo provides services for in vitro and in vivo pharmacology, has a strong expertise in the fields of Cell biology/oncology, medicinal chemistry and formulation. New is the department of medical devices (diagnostics) and Bio-Analytics. Synovo was founded in 2004 with 3 employees and has steadily grown since then. Synovo currently occupies modern laboratories and animal facilities in two technology parks in Tübingen, and employs 40 people, including researchers (chemists, pharmacologists, biologists and engineers). Synovo has ca. 25 patent applications granted or in process. Two products from its research efforts are licensed and in development by major firms.
Significant infrastructure
Synovo’s chemistry infrastructure includes 3 HPLC coupled Mass Sprectrometers for bioanalysis and, UV and fluorescence HPLC, NMR, IR, Plate readers, dryers and reaction vessels. Its Biology infrastructure includes animal facilities for ca. 4000 mice, rats and hamster, cell culture, flow cytometry, fluorescence microscopy, clinical chemistry and PCR.
• Medicinal Chemistry and reagents
• Customer-friendly processes
Expertise in pharmacokinetics, preformulation, immuno-oncology, Liver and metabolic diseases (Diabetes, NASH models), Inflammatory diseases (GI, muskulo-skeletal, CNS), Airway models and Alzheimer’s models. A new development is an increasing capacity for Opthalmology studies.

Biotech Companies, Pharmaceutical Companies, Analytics, Proteins/Peptides, Biotech Services, Contract Research & Development, Cells/Cell Lines, Classical Pharmaceuticals
Website address: https://www.bio-pro.de/en/service/details